Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment [ J ] Diab Vasc Dis Res, 2012,9 (2) : 85-88.Gore MO, McGuire DK. Drugs for type 2 diabetes mellitus: The imperative for cardiovascular outcome assessment. Diabetes and Vascular Disease Research 2012; 9...
The FDA has approved two new drugs of the thiazolidinedione class to treat type 2 diabetes mellitus. Rosiglitazone (Avandia, SmithKline Beecham,
Rethinking the appraisal and approval of drugs for type 2 diabetes. BMJ 2015;351:h5260.Naci H, Lehman R, Wouters OJ, Goldacre B, Yudkin JS. Rethinking the appraisal and approval of drugs for type 2 diabetes. BMJ. 2015;351:h5260. http://dx.doi. org/10.1136/bmj.h5260...
Several new emerging drugs and drug classes for the management of diabetes are under development, includi... Park, IeByung 被引量: 2发表: 2007年 Management of type 2 diabetes in the obese patient: current concerns and emerging therapies. The aims of this review are (1) to examine the ...
The most comprehensive diabetes news aggregator on the web. Type I, Type II, Artificial Pancreas, Drugs, Glucose & Insulin, Lifestyle & Diet, Medical Research, and Other News.
In addition, emerging strategies for the treatment of diabetes will be described, among them the inhibition of glucagon action and anti-inflammatory drugs. Their suitability as ideal anti-diabetic drugs will be discussed. 展开 关键词: type 2 diabetes mellitus anti-diabetic drugs insulin resistance ...
Newer Therapies for Diabetes Management. The article presents abstracts on new drugs for the treatment of type 2 diabetes including use of drug Canagliflozin from the firm Mitsubishi Tanabe Pharma, role of sodium–glucose co transporter-2 in renal glucose reabsorption, and deve... Garg,Satish,K....
diagnoseddiabetes,combinedwithpatientsandhealthstatus,tochoosetheapplicationofsulfonylurea,#glucosidaseinhibitor,thiazolidineketone,twononsulfonylureaantidiabeticdrug(glinides),this5kindsofbasicdrugsforthetreatmentoftype2diabetes,andanothertwodipeptidylpeptidaseinhibitorclinicaldataisless.Conclusion:Patientswithdiabetesshould...
Type 2 diabetes has been identified as a risk factor for Alzheimer's disease (AD) and Parkinson's disease (PD). In the brains of patients with AD and PD, insulin signaling is impaired. This finding has motivated new research that showed good effects using drugs that initially had been deve...
SGLT2 inhibitors were approved by the FDA in 2013 for use with diet and exercise to lower blood sugar in adults with type 2 diabetes. In its statement, the FDA asked patients who take these drugs to seek medical attention immediately if they experience any symptoms of tenderness, redness, ge...